Agravitae Publishes Graviola Extract Study, Validating 4.09% Active Ingredient Concentration
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 10 2025
0mins
Source: Globenewswire
- Transparency Enhancement: Agravitae's collaboration with Cambium Analytica has resulted in the publication of an analytical study on graviola extract, validating a 4.09% concentration of active ingredients, thereby addressing the market's transparency gap in botanical supplements.
- Extraction Method Optimization: The research indicates that using 100% ethanol with sonication yields the highest concentration of annonacin at 0.524%, demonstrating ethanol's effectiveness in extracting bioactive compounds from graviola leaves, which enhances the product's market competitiveness.
- Leaf Maturity Impact: The study reveals that young graviola leaves contain twice the concentration of active compounds compared to mature leaves, at 0.533% and 0.251% respectively, emphasizing the critical influence of plant part selection on product quality consistency and efficacy.
- Industry Benchmark Establishment: Agravitae's research sets a benchmark for standardization in graviola extract products, promoting compliance and transparency in the botanical supplement market, thereby enhancing consumer trust in the brand.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
